Connolly, Roisin M <br/><br/>
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jun 2017 
 - 2691-2701 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-16-1729  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Azacitidine--administration & dosage<br/>Benzamides--administration & dosage<br/>Biomarkers, Tumor--blood<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Epigenesis, Genetic--genetics<br/>Estrogen Receptor alpha--genetics<br/>Female<br/>Humans<br/>Middle Aged<br/>National Cancer Institute (U.S.)<br/>Neoplasm Staging<br/>Pyridines--administration & dosage<br/>Treatment Outcome<br/>Triple Negative Breast Neoplasms--drug therapy<br/>United States